$EDIT

Editas Medicine

$EDIT

Editas Medicine

Past 12mo:2mentions1voices

All voices2 mentions since Jan 2026calls only

Loading price chart…

Recent mentions

2 mentions

@investmentguru_Jan 25, 2026 · 4:33 PM

$RXRX $KROS $EDIT @grok special

Open on X

@investmentguru_Jan 25, 2026 · 3:36 PM

Top 10 Biotech Stocks to Watch in 2026 $PRME – Prime Medicine Precision genetic medicine with deep science and long-term pipeline potential. $RXRX – Recursion Pharmaceuticals AI-driven drug discovery platform accelerating therapeutic development. $ABCL – AbCellera Biologics Antibody discovery partner with big pharma programs and diversified pipeline. $KROS – Keros Therapeutics Small-cap biotech showing massive year-over-year revenue growth and rapid expansion in its pipeline. $GERN – Geron Gene-targeting therapeutics with huge reported revenue growth metrics. $SGMO – Sangamo Therapeutics Cell and gene therapy company with notable growth in recent quarters. $LXRX – Lexicon Pharmaceuticals Clinical-stage biotech with strong growth and a diversified asset base. $MGTX – MeiraGTx Gene therapy developer with increasing pipeline and research expansion. $EDIT – Editas Medicine Gene editing biotech driving next-gen therapies with robust growth numbers. $ENSC – Ensysce Biosciences Ultra-small cap with huge revenue expansion — moonshot potential but high risk.

Open on X

Frequently asked

Who mentions $EDIT most on Surfaced?

@investmentguru_ (InvestmentGuru) mentions $EDIT most — 2 mentions in the past 12 months.

When was $EDIT first mentioned on Surfaced?

The earliest tracked mention of $EDIT in the Surfaced archive was on Jan 25, 2026.

How many voices track $EDIT?

1 FinTwit voice has mentioned $EDIT 2 times in the past 12 months.

What kind of voices mention $EDIT most?

$EDIT is mentioned most by Long Research voices on Surfaced.